Global Health logo

Global Health financials: balance sheet, profit and loss, cash flow

NSE: MEDANTABSE: 543654Healthcare ServicesSmall Cap

Global Health Limited · Face value ₹2 · Listed Nov 2022 · Issue price ₹336
Last close ₹1,283.00up ₹22.40 (1.78%)BSE ₹1,284.05

Share price at the NSE close on 28 Oct 2026. Previous close ₹1,260.60.

28 Oct: open ₹1,260.60, high ₹1,295.10, low ₹1,243.40

52-week range of traded prices to 28 Oct 2026
₹956.00Low, 30 Mar 2026₹1,544.00High, 27 Aug 2026
Market cap
₹34,497 Cr262nd largest listed
P/E
62.02
P/B
8.71
Dividend yield
0.04%
ROE
15.1%
ROCE
14.2%
Debt to equity
0.30
Volume, NSE
1,30,20547.0% delivered

Global Health's financial statements for the 4 years to Mar 2026, consolidated: the company and its subsidiaries together, with the twelve months to Jun 2026 after them.

4 years at a glance

₹ crore, years to March.Global Health annual reports

Revenue, net profit and borrowings, ₹ crore

  • Revenue
  • Net profit
  • Borrowings
2,694326842Mar 233,275478419Mar 243,692481328Mar 254,4105541,190Mar 26
Peak revenue ₹4,410 Cr, year to Mar 2026; lowest ₹2,694 Cr, year to Mar 2023

Operating and net margin, per cent

  • Operating margin
  • Net margin
24.4%12.1%22.7%24.4%23.8%20.8%12.1%14.6%13.0%12.6%Mar 23Mar 24Mar 25Mar 26

Results for the year to Mar 2026

Consolidated: the company and its subsidiaries together. ₹ crore.

From revenue to net profit

  1. Revenue4,410
  2. Materials and goods−997
  3. Employee costs−1,096
  4. Other expenses−1,398
  5. Operating profit919
  6. Depreciation−223
  7. Other income+99
  8. One-off items−1.0
  9. Finance costs−79
  10. Profit before tax715
  11. Tax−161
  12. Net profit554

What the company owns

  • Plant, investments and other assets₹4,285 Cr
  • Cash and bank₹1,130 Cr
  • Receivables₹411 Cr
  • Inventory₹79 Cr

What pays for it: net worth and liabilities

  • Net worth₹3,984 Cr
  • Borrowings₹1,190 Cr
  • Other liabilities₹488 Cr
  • Owed to suppliers₹242 Cr

Profit and loss

Consolidated, ₹ crore, years to March. The last column is the twelve months to Jun 2026, the latest four quarters added.Global Health quarterly results

₹ croreMar 2023Filed 27 MayMar 2024Mar 2025Filed 15 MayMar 2026Jun 2026Twelve months
Revenue from operations2,6943,2753,6924,4104,683
2,0822,4762,8153,4913,705
Materials and goods bought6257598809971,052
Employee costs6347358251,0961,159
Other expenses8229821,1111,3981,494
Operating profit before depreciation612799877919979
Operating margin22.7%24.4%23.8%20.8%20.9%
Materials, % of revenue23.2%23.2%23.8%22.6%22.5%
Employee costs, % of revenue23.5%22.4%22.3%24.9%24.7%
Other expenses, % of revenue30.5%30.0%30.1%31.7%31.9%
Depreciation and amortisation150173194223246
Operating profit after depreciation462626683697732
Other income65757999100
Finance costs7874657992
Profit before one-off items and tax449627697716741
One-off items00−50−1−21
Profit before tax449627647715720
123149166161168
326478481554552
Other comprehensive income1−1−14−2
Total comprehensive income328477481558551
Net margin12.1%14.6%13.0%12.6%11.8%

Balance sheet

Consolidated, ₹ crore, at 31 March.

₹ croreMar 2023Filed 27 MayMar 2024Mar 2025Filed 15 MayMar 2026
2,4282,9063,3883,984
2,4282,9063,3863,962
Share capital54545454
Reserves2,3752,8523,3333,908
Belonging to outside owners of subsidiaries–0123
8424193281,190
573618619627
1,1157817601,294
Total assets4,1164,3044,7665,905
2,5362,7953,2334,230
1,5791,5091,5331,675
Net debt−436−756−79460
Borrowings are counted again inside the liabilities due within a year and after a year.

Cash flow

Consolidated, ₹ crore, years to March.

₹ croreMar 2023Filed 27 MayMar 2024Mar 2025Filed 15 MayMar 2026
645612624714
751790788830
32−59−68−89
Receivables−21−48−95−130
Inventories−7−60−12
Payables6021354
Other working capital0−6140
Tax paid−106−177−164−119
Capital spending236279517838
Free cash flow409334107−124
−342−441−721−1,065
346−514−97248
Dividends paid00013
Shares bought back0000
Shares issued479010
Net change in cash648−343−194−103
Capital spending is part of cash from investing, and dividends paid, shares bought back and shares issued are part of cash from financing. Each is shown as an amount on a line of its own, and the section's other items are in its total only.

Per share

Consolidated, ₹ per share, years to March.Global Health dividend history

₹ per shareMar 2023Filed 27 MayMar 2024Mar 2025Filed 15 MayMar 2026
Earnings per share₹12.58₹17.80₹17.92₹20.71
Diluted earnings per share₹12.57₹17.80₹17.92₹20.66
Dividend per share––₹0.50₹0.50
Book value per share₹90.54₹108.21₹126.08₹147.44
Dividend payout––2.8%2.4%
Shareholder yield−3.4%0.0%0.0%0.1%
Market cap at the year end (₹ crore)14,13235,46332,18525,833

Ratios

Consolidated, years to March.Global Health PE ratio and valuation

RatioMar 2023Filed 27 MayMar 2024Mar 2025Filed 15 MayMar 2026
Revenue growth–21.6%12.7%19.4%
Operating profit growth–30.5%9.8%4.8%
Net profit growth–46.6%0.7%15.1%
Earnings per share growth–41.5%0.7%15.6%
13.4%17.9%15.3%15.1%
–4.5 pts−2.6 pts−0.2 pts
From the net margin–2.8 pts−1.9 pts−0.5 pts
From asset turnover–3.1 pts0.7 pts0.2 pts
From borrowing–−1.3 pts−1.5 pts0.1 pts
Return on capital employed14.1%18.8%18.4%13.5%
Cash conversion197.7%128.0%129.6%128.9%
Interest cover5.98.510.58.8
Debt to equity0.350.140.100.30
Receivable days26242934
Inventory days35322829
Payable days114908189
Cash conversion cycle, days−52−34−24−26
Working capital days−22−17−14−2
Asset turnover0.650.780.810.83
Assets per rupee of net worth1.701.581.441.45
Sales per rupee of plant1.581.811.871.17
Capital spending to depreciation1.571.612.673.77
Plant being built, % of plant in use19.1%21.3%26.8%3.5%

Growth and returns over 3, 5 and 10 years

Consolidated: the company and its subsidiaries together. Each window ends with the year to Mar 2026.

Return on assets, latest year
10.4%
Cash from operations against operating profit
77.7%
Measure5 years3 years
Revenue growth, yearly rate–17.9%
Profit growth, yearly rate–19.5%
Return on equity, average15.5%16.1%
Return on capital employed, average16.2%16.9%
Operating margin, average22.9%23.0%
Net margin, average13.1%13.4%
Asset turnover, average0.770.81
Cash conversion cycle, days, average−34−28
Interest cover, average8.49.2
Debt to equity, average0.220.18

Where the cash came from and went

Consolidated: the company and its subsidiaries together. ₹ crore, added up over each window, which ends with the year to Mar 2026.

₹ crore3 yearsLatest year
Cash from operations1,950714
Cash from investing−2,227−1,065
Cash from financing−363248
Capital spending1,633838
Dividends paid1313
Shares bought back00
Shares issued for cash10
Borrowings raised654369
Borrowings repaid77812

Accounting checks

Consolidated, years to March. Published tests of whether reported profit is backed by cash and the balance sheet.

CheckMar 2023Mar 2024Mar 2025Mar 2026
Piotroski score, out of 9Published threshold 3 points out of 9––67
Altman Z-scorePublished threshold 1.817.2017.6916.4810.40
Beneish M-scorePublished threshold −1.78–−2.37−2.20−2.69
Profit not backed by cash, % of assetsPublished threshold 10 per cent of average total assets–7.2912.7616.96
Cash from operations to profit, 3 yearsPublished threshold 0.7 times––1.461.29
Receivables growth less revenue growthOur threshold 0 percentage points–−10.6922.8121.44
Inventory growth less cost-of-goods growthOur threshold 0 percentage points–−10.71−15.414.32
Other current assets growth less revenue growthOur threshold 5 per cent of revenue–0.140.010.06
Assets under construction, years of additionsOur threshold 2 years of additions–1.391.480.07
Effective tax ratePublished threshold 17.16 per cent27.4223.7725.6422.51
Tax charged less tax paid, % of profitOur threshold 10 percentage points3.80−4.530.265.81
A threshold marked as ours has no published figure; it is the line we read the check against.

Credit ratings

An agency's view of the chance the company repays a borrowing on time, from AAA, the highest, down to D, in default.

DateAgencyBorrowing ratedRatingOutlookAmount, ₹ Cr
16 Dec 2025CRISIL Ratings LimitedBank FacilitiesCrisil A1+Review, Re-affirm390
16 Dec 2025CRISIL Ratings LimitedBank FacilitiesCrisil AAReview, UpgradeStable400
The latest rating on each borrowing. The agency's name opens its reasoning for the rating.